Digestive tolerance, medication history, hydration, nutrition, and risk factors need review
Summary: Retatrutide cannot be taken by anyone outside a clinical trial, as it remains an investigational drug with no UK or international regulatory approval, and not all individuals would be suitable candidates even if it were approved
Rybelsus is a GLP-1 receptor agonist licensed for type 2 diabetes treatment, working by stimulating insulin secretion, suppressing glucagon, and slowing gastric emptying
Even if you eat a balanced diet, your body may struggle to get the full benefits due to absorption challenges that come with age or lifestyle factors
2(3): 2502 De Grandis D, Minardi C
ONLY ONCE A WEEK INJECTION WITH COMPOUNDED GLP-1 BLEND